Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;121(8):2421-2432.
doi: 10.1007/s00436-022-07548-x. Epub 2022 Jun 3.

Detection of metronidazole resistance in Trichomonas vaginalis using uncultured vaginal swabs

Bongekile Ngobese  1 , Ravesh Singh  2   3 , Khine Swe Swe- Han  2   3 , Partson Tinarwo  4 , Nonkululeko Mabaso  5 , Nathlee S Abbai  5
Affiliations

Detection of metronidazole resistance in Trichomonas vaginalis using uncultured vaginal swabs

Bongekile Ngobese et al. Parasitol Res. 2022 Aug.

Abstract

Trichomonas vaginalis (T. vaginalis) is the most prevalent sexually transmitted infection (STI) globally. Metronidazole is the drug of choice for treating T. vaginalis infections although metronidazole-resistant T. vaginalis has been reported in clinical isolates. The purpose of this study was to determine the presence of mutations in nitroreductase genes associated with metronidazole resistance in vaginal swabs testing positive for T. vaginalis. This study included 385 human immunodeficiency virus (HIV)-positive pregnant women. Vaginal swabs were collected from consenting pregnant women and used for the detection of T. vaginalis using the TaqMan assay. From the vaginal swabs, nitroreductase genes ntr4 and ntr6 containing mutations associated with metronidazole resistance were amplified using a quantitative polymerase chain reaction (PCR) assay. To validate the PCR assay, T. vaginalis cultured isolates with known metronidazole resistance profiles were used as controls in the mutation detection assays. The prevalence of T. vaginalis in the study population was 12.2% (47/385). Mutations associated with resistance to metronidazole were detected in more than 40% of the samples tested, i.e. 21/47 (45%) and 24/47 (51%) for ntr4 and ntr6, respectively. A total of 19 samples (40%) carried mutations for both ntr4 and ntr6 genes associated with metronidazole resistance. The validation assays showed a positive correlation between phenotypic and genotypic resistance profiles. This study found a high prevalence of mutations associated with metronidazole resistance. This is concerning since metronidazole is currently used in the syndromic management of STIs in South Africa. Molecular-based assays for monitoring metronidazole resistance profiles using nitroreductase genes may serve as a feasible method for antimicrobial surveillance studies for T. vaginalis.

Keywords: HIV; Metronidazole resistance; Pregnancy; South Africa; Trichomonas vaginalis.

PubMed Disclaimer

References

    1. Abdel-Magied AA, El-Kholya E-SI, Abou El-Khair SM, Abdelmegeed ES, Hamoudaa MM, Mohamed SA, El-Tantawy NL (2017) The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Parasitol Res 116:3125–3130 - PubMed - DOI
    1. Abdel-Magied AA, Hammouda MM, Mosbah A, El-Henawy AA (2017) In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates. J Infect Chemother 23:230–233 - PubMed - DOI
    1. Akbari Z, Matini Mx (2017) The study of trichomoniasis in pregnant women attending Hamadan city health centers in 2015. Avicenna J Clin Microbiol Infect 4
    1. Alessio C, Nyirjesy P (2019) Management of resistant trichomoniasis. Curr Infect Dis Rep 21:1–7 - DOI
    1. Bosserman EA, Helms DJ, Mosure DJ, Secor WE, Workowski KA (2011) Utility of antimicrobial susceptibility testing in Trichomonas vaginalis–infected women with clinical treatment failure. Sex Transm Dis 38:983–987 - PubMed - DOI

LinkOut - more resources